top of page


Upcoming Pegozafermin NASH Readout!
Summary: The upcoming readout from ETNB includes Phase 2b data from the pegozafermin trial in NASH. This is a Suspected Mover for Q1...
Feb 22, 20233 min read
Â
Â
Â
ESMO 2022 Investor Hub
Updated 9/6/22 Summary The Euorpean Society for Medical Oncology (ESMO) takes place from Sept 9-13, 2022 in Paris ESMO is "the most...
Sep 1, 20223 min read
Â
Â
Â


Biopharma Daily Pulse - 08/15/22
$XBI $94.90 | +1.19% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
Aug 15, 20221 min read
Â
Â
Â


Free Biopharma Daily Pulse - 08/15/22
$XBI $94.90 | +1.19% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
Aug 15, 20221 min read
Â
Â
Â


Biopharma Mid Morning Pulse - 08/15/22
(Posted 10:50am CST) $XBI $94.05 | +0.29% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume...
Aug 15, 20221 min read
Â
Â
Â


Free Biopharma Mid Morning Pulse - 08/15/22
(Posted 10:50am CST) $XBI $94.05 | +0.29% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume...
Aug 15, 20221 min read
Â
Â
Â
J.P. Morgan Healthcare Conference
The 40th Annual J.P. Morgan Health Care Conference is taking place fully online from January 10-13, 2022. "This premier conference is...
Dec 31, 20212 min read
Â
Â
Â
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page
